The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Tumor Acidity, Chemoresistance and Proton Pump Inhibitors
Abstract
Tumor microenvironment may play a key role in tumor malignancy. It is hypothesized that hypoxia and acidity may contribute to the progression from benign to malignant growth. In particular, the unfavorable environment may induce the selection of tumor cells able to survive in acidic and hypoxic conditions. In fact, the common components of the cancer phenotype result from active selection, and characteristics of tumor microenvironment may create the best condition for this selection. Acidity, in particular, has been shown to have a role in resistance to chemotherapy, proliferation and metastatic behavior. In fact, a mechanism of resistance to cytotoxic drugs may be the alteration of the tumor microenvironment through changes of the pH gradient between the extracellular environment and cell cytoplasm. The extracellular pH of solid tumors is significantly more acidic than that of normal tissues, thus impairing the uptake of weakly basic chemotherapeutic drugs and reducing their effect on tumors. An important determinant of tumor acidity is the anaerobic metabolism that allows selection of cells able to survive in an hypoxic-anoxic environment with the generation of lactate. However, this is not the major mechanism responsible for the development of an acidic environment within solid tumors. It appears clear that a complex framework of protein-protein, protein-lipid and lipid-lipid interactions underlay the pH homeostasis in mammalian cells. Malignant tumor cells seem to hijack some of these mechanism to protect themselves from the acidic environment and to maintain acidity in an environment unsuitable for normal or more differentiated cells. Recent data suggest that vacuolar-type (V-type) H(+)-ATPases, that pump protons across the plasma membrane, may have a key role in the acidification of the tumor microenvironment. Some human tumor cells are characterized by an increased V-type H(+)-ATPase expression and activity, and pretreatment with proton pump inhibitors -- a class of H(+)-ATPase inhibitors -- sensitized tumor cell lines to the effect of a variety of anticancer drugs. Proton pump inhibitor pretreatment has been associated with inhibition of V-type H(+)-ATPase activity and increase in both extracellular pH and pH of lysosomal organelles. In vivo experiments in human/mouse xenografts have shown that oral pretreatment with proton pump inhibitors is able to sensitize human solid tumors to anticancer drugs. These data suggest that tumor alkalinization may represent a key target of future antitumor strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“It was postulated 50 years ago that tumors were acidic due to their marked rate of lactic acid production [4].”
BackgroundWhy Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
(1989) · PubMed · Cited by 1,639
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Self-citationHypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Studies of human tumors by MRS: A review
Negendank, W. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050518 · Cited by 660
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Izumi, H., Torigoe, T., Ishiguchi, H., Uramoto, H., Yoshida, Y., Tanabe, M., Ise, T., Murakami, T., Yoshida, T., Nomoto, M., et al. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00106-3 · Cited by 613
Griffiths, Jr. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.326 · Cited by 594
Huber, V., Fais, S., Iero, M., Lugini, L., Canese, P., Squarcina, P., Zaccheddu, A., Colone, M., Arancia, G., Gentile, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.045 · Cited by 524
Self-citationAcidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Luciani, F., Spada, M., De Milito, A., Molinari, A., Rivoltini, L., Montinaro, A., Marra, M., Lugini, L., Logozzi, M., Lozupone, F., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh305 · Cited by 435
Self-citationBourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
Taylor, D. D., & Gerçel-Taylor, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602316 · Cited by 391
Väänänen, H. K., Karhukorpi, E. K., Sundquist, K., Wallmark, B., Roininen, I., Hentunen, T., Tuukkanen, J., & Lakkakorpi, P. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.3.1305 · Cited by 391
Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
Rozhin, J., Sameni, M., Ziegler, G., & Sloane, B. F. (1994) · PubMed · Cited by 373
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Tumor acidity, ion trapping and chemotherapeutics
Mahoney, B. P., Raghunand, N., Baggett, B., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00467-2 · Cited by 364
Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate
Gillies, R. J., Liu, Z., & Bhujwalla, Z. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.1.c195 · Cited by 351
An evolutionary model of carcinogenesis.
Gatenby, R. A., & Vincent, T. L. (2003) · PubMed · Cited by 318
Enhancement of chemotherapy by manipulation of tumour pH
Raghunand, N., He, X., Sluis, R. V., Mahoney, B., Baggett, B., Taylor, C. W., Paine-Murrieta, G., Roe, D., Bhujwalla, Z. M., & Gillies, R. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690455 · Cited by 316
Saitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., & Banerjee, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210328200 · Cited by 291
Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells
Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M., & Gillies, R. J. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.4.c1015 · Cited by 291
Extracellular Acidification Alters Lysosomal Trafficking in Human Breast Cancer Cells
Glunde, K., Guggino, S. E., Solaiyappan, M., Pathak, A. P., Ichikawa, Y., & Bhujwalla, Z. M. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80037-4 · Cited by 285
Intracellular pH and the control of multidrug resistance.
Simon, S., Roy, D., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1128 · Cited by 276
Schindler, M., Grabski, S., Hoff, E., & Simon, S. M. (1996) · Biochemistry · doi:10.1021/bi952234e · Cited by 269
Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
Altan, N., Chen, Y., Schindler, M., & Simon, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1583 · Cited by 265
The proton-pump inhibitors: Similarities and differences
Horn, J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80032-6 · Cited by 240
Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238
Yamagata, M., Hasuda, K., Stamato, T., & Tannock, I. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.289 · Cited by 212
Clastogenicity of low pH to various cultured mammalian cells
Morita, T., Nagaki, T., Fukuda, I., & Okumura, K. (1992) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(92)90235-t · Cited by 210
Newell, K., Franchi, A., Pouysségur, J., & Tannock, I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1127 · Cited by 197
pH and drug resistance in tumors
Raghunand, N., & Gillies, R. J. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0119 · Cited by 194
Tumor acidity, ion trapping and chemotherapeutics
Raghunand, N., Mahoney, B. P., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00468-4 · Cited by 182
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism
Montcourrier, P., Silver, I., Farnoud, R., Bird, I., & Rochefort, H. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018446104071 · Cited by 176
Dietel, M., Arps, H., Lage, H., & Niendorf, A. (1990) · PubMed · Cited by 149
The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
Wallmark, B., Larsson, H., & Humble, L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38778-1 · Cited by 144
Elevated expression of vacuolar proton pump genes and cellular ph in cisplatin resistance
Murakami, T., Shibuya, I., Ise, T., Chen, Z., Akiyama, S., Nakagawa, M., Izumi, H., Nakamura, T., Matsuo, K., Yamada, Y., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1418 · Cited by 144
Luciani, F., Molinari, A., Lozupone, F., Calcabrini, A., Lugini, L., Stringaro, A., Puddu, P., Arancia, G., Cianfriglia, M., & Fais, S. (2002) · Blood · doi:10.1182/blood.v99.2.641 · Cited by 143
Self-citationRegulation of intracellular pH in human melanoma: potential therapeutic implications.
Wahl, M., Owen, J. A., Burd, R., Herlands, R., Nogami, S. S., Rodeck, U., Berd, D., Leeper, D. B., & Owen, C. S. (2002) · PubMed · Cited by 141
Raghunand, N., Martínez–Zaguilán, R., Wright, S. H., & Gillies, R. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00021-0 · Cited by 139
Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes
Hurwitz, S. J., Terashima, M., Mizunuma, N., & Slapak, C. A. (1997) · Blood · doi:10.1182/blood.v89.10.3745 · Cited by 137
Wallmark, B., Brändström, A., & Larsson, H. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90406-1 · Cited by 136
Sun‐Wada, G., Wada, Y., & Futai, M. (2003) · Cell Structure and Function · doi:10.1247/csf.28.455 · Cited by 127
Raghunand, N., Mahoney, B. P., van Sluis, R., Baggett, B. K., & Gillies, R. J. (2001) · Neoplasia · doi:10.1038/sj.neo.7900151 · Cited by 114
Lugini, L., Lozupone, F., Matarrese, P., Funaro, C., Luciani, F., Malorni, W., Rivoltini, L., Castelli, C., Tinari, A., Piris, A., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000098425.03006.42 · Cited by 108
Self-citationOuar, Z., Bens, M., Vignes, C., Paulais, M., PRINGEL, C., Fleury‐Feith, J., Cluzeaud, F., Lacave, R., & Vandewalle, A. (2003) · Biochemical Journal · doi:10.1042/bj20021411 · Cited by 100
Agastya, G., West, B. C., & Callahan, J. M. (2000) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970009016425 · Cited by 91
Animal pharmacodynamics of omeprazole. A survey of its pharmacological propertiesin vivo
Larsson, H., Mattson, H., Sundell, G., & Carlsson, E. I. (1985) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528509095817 · Cited by 86
Proton pump inhibitors may reduce tumour resistance
Milito, A. D., & Fais, S. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.7.1049 · Cited by 77
Self-citationThe mechanism of action of omeprazole—a survey of its inhibitory actionsin vitro
Wallmark, B., Lorentzon, P., & Larsson, H. (1985) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528509095818 · Cited by 68
Involvement of Vacuolar H+-Adenosine Triphosphatase Activity in Multidrug Resistance in HL60 Cells
Marquardt, D. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.15.1098 · Cited by 68
McCoy, C., Parkins, C., Chaplin, D. J., Griffiths, J. R., Rodrigues, L. M., & Stubbs, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.431 · Cited by 58
Ouar, Z., Lacave, R., Bens, M., & Vandewalle, A. (1999) · Cell Biology and Toxicology · doi:10.1023/a:1007521430236 · Cited by 55
Sabolić, I., Brown, D., Verbavatz, J., & Kleinman, J. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.6.f868 · Cited by 55
Dill, C., Gramain, M.-P., Merlin, J., Marchal, S., & Guillemin, F. (2000) · Cytometry · Cited by 50
Raghunand, N., & Gillies, R. J. (2001) · Novartis Foundation symposium · doi:10.1002/0470868716.ch14 · Cited by 47
Puscas, I. I., Coltąu, M., Baican, M., & Domuťa, G. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34931-6 · Cited by 45
Coss, R. A., Storck, C., Daskalakis, C., Berd, D., & Wahl, M. (2003) · PubMed · Cited by 42
Clary, I., Doherty, G., Morán, E., & CLYNES, M. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00003-8 · Cited by 37
MicroArray Data Simulator For Improved Selection of Differentially Expressed Genes
Singhal, S. K., Kyvernitis, C. G., Johnson, S. W., et al. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.431 · Cited by 37
Cianfriglia, M., Cenciarelli, C., Tombesi, M., Barca, S., Mariani, M., Morrone, S., Santoni, A., Samoggia, P., Alessio, M., & Malavasi, F. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450118 · Cited by 24
Weak acids, weak bases, and intracellular pH
Roos, A. (1978) · Respiration Physiology · doi:10.1016/0034-5687(78)90080-4 · Cited by 23
Bobichon, H., Colin, M., Depierreux, C., Liautaud-Roger, F., & Jardillier, J. C. (1996) · PubMed · Cited by 14
Omeprazole and SCH 28080 Inhibit Acid Secretion by the Turtle Urinary Bladder
Graber, M. L., & Devine, P. (1993) · Kidney & Blood Pressure Research · doi:10.1159/000173771 · Cited by 7
Cited by
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Self-citationLactate metabolism in human health and disease
Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J.-X., Wang, Z., & Yu, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01151-3 · Cited by 1,454
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.001 · Cited by 595
Terman, A., Kurz, T., Navratil, M., Arriaga, E. A., & Brunk, U. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2598 · Cited by 490
“It has been recognized that tumor cells often secrete lysosomal proteases, which, in combination with the previously described acidification of their surroundings that enhances the activity of lysosomal proteolytic enzymes, may help them to infiltrate and metastasize (58, 144, 151, 165, 181, 189, 249).”
Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088193 · Cited by 354
Self-citation
Metadata
- Authors
- De Milito, A., & Fais, S.
- Venue
- Future Oncology
- Publisher
- Informa UK Limited
- Published
- 2005-11-24
- Volume
- 1
- Issue
- 6
- Pages
- 779-786
- ISSN
- 1479-6694 (ISSN-L)
- 1744-8301
- OpenAlex
- W2143433681
- Cited by
- 265
- References
- 67
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.